Edwards Lifesciences officer has 398 shares withheld

A senior Edwards Lifesciences officer had shares withheld to cover taxes on vesting equity, leaving 43,926 shares directly held.

Rhea-AI Filing Summary

Edwards Lifesciences Corp (EW) reported that officer Daveen Chopra had 398 shares of common stock withheld on September 11, 2026, to pay tax withholding obligations related to vesting equity awards, treated as a disposition under insider rules. After this withholding, Chopra directly holds 43,926 shares of Edwards Lifesciences common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Tax Withholding: 398 shares

Tax Withholding 1 txn

Insider Chopra Daveen

Role CVP, TMTT, Surgical & IHFM

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	398	$86.77	$35K

Holdings After Transaction: Common Stock — 43,926 shares (Direct)

Footnotes (1)

1. F1. Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).

Key Figures

Shares withheld for tax: 398 shares Per-share value for withholding: $86.77 per share Shares held after transaction: 43,926 shares

3 metrics

Shares withheld for tax 398 shares Common stock withheld on September 11, 2026 to satisfy tax withholding obligations

Per-share value for withholding $86.77 per share Valuation used for the 398 shares withheld for tax on September 11, 2026

Shares held after transaction 43,926 shares Direct holdings of Edwards Lifesciences common stock by Daveen Chopra following the transaction

Key Terms

beneficial ownership, tax withholding obligations, Rule 16b-3(e)

3 terms

beneficial ownership financial

"This Form 4 reflects changes in beneficial ownership only"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

tax withholding obligations financial

"shares withheld by the Issuer to satisfy tax withholding obligations incident"

Rule 16b-3(e) regulatory

"incident to the vesting of securities in accordance with Rule 16b-3(e)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Edwards Lifesciences (EW) disclose for Daveen Chopra?

Edwards Lifesciences disclosed that officer Daveen Chopra had 398 shares of common stock withheld on September 11, 2026, to satisfy tax withholding obligations related to the vesting of equity awards, reported as a disposition under insider reporting rules.

How many Edwards Lifesciences (EW) shares does Daveen Chopra hold after this Form 4?

After the reported tax-withholding transaction, Daveen Chopra directly holds 43,926 shares of Edwards Lifesciences common stock, according to the Form 4 disclosure.

Was the Edwards Lifesciences (EW) Form 4 transaction under a Rule 10b5-1 plan?

No. The Form 4 for Edwards Lifesciences indicates that no Rule 10b5-1 trading plan is reported in connection with this tax-withholding disposition.

What price per share was used for the Edwards Lifesciences (EW) tax-withholding shares?

The 398 shares withheld for tax purposes were valued at $86.77 per share, as stated in the Form 4 for the September 11, 2026 transaction.

Does this Edwards Lifesciences (EW) Form 4 reflect all of Daveen Chopra’s holdings?

No. The Form 4 states it reflects changes in beneficial ownership only and does not identify other Edwards Lifesciences securities beneficially owned by Daveen Chopra.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 07:15 PM EDT Accepted by SEC EDGAR 09/11/2026 - 07:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chopra Daveen

(Last) (First) (Middle)

ONE EDWARDS WAY

(Street)

IRVINE CALIFORNIA 92614

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Edwards Lifesciences Corp [ EW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CVP, TMTT, Surgical & IHFM

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		F(1)		398	D	$86.77	43,926	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

	Linda J. Park, Attorney-in-Fact	09/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)